Loss of HIV-1-specific immunity during treatment interruption in 2 chronically infected patients [2]

JAMA

Volumn 288, Issue 2, 2002, Pages 162-164

  Blankson, Joel N ^a   Gallant, Joel E ^a   Quinn, Thomas C ^a   Bartlett, John G ^a   Siliciano, Robert F ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

CASE REPORT; CHRONIC DISEASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LETTER; LEUKOCYTE COUNT; PRIORITY JOURNAL; SEROCONVERSION; VIREMIA; VIRUS INFECTION; VIRUS LOAD;

EID: 0037055056     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia
2. Absence of recoverable infectious virus and unique immune responses in an asymptomatic HIV+ long-term survivor
3. Resistance to replication of human immunodeficiency virus challenge in SCID-Hu mice engrafted with peripheral blood mononuclear cells of nonprogressors is mediated by CD8(+) T cells and associated with a proliferative response to p24 antigen
4. Immune control of HIV-1 after early treatment of acute infection
5. Proliferative responses to Human immunodeficiency virus type 1 (HIV-1) antigens in HIV-1-infected patients with immune reconstitution
6. High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation